santé – Le futur numéro 2 de la santé a touché 33 000 euros de rémunération de BigPharma

This written question asks about potential conflicts of interest regarding a health official receiving payments from a pharmaceutical company. It seeks transparency on financial ties that could influence public health policy. The question affects the public's trust in health institutions and raises concerns about the influence of pharmaceutical companies on healthcare decisions.